期刊文献+

食管癌肺转移的有效预后模型:列线图 被引量:1

Nomogram: an effective prognostic model for esophageal cancer with lung metastasis
暂未订购
导出
摘要 目的利用临床病理因素建立模型来预测食管癌肺转移患者的预后情况。方法收集美国国家癌症研究所监测、流行病学和最终结果(SEER)数据库中2010—2015年194例食管癌肺转移患者的信息。通过X-tile软件确定年龄的最佳截断值。通过SPSS(v25.0)用log-rank方法和Cox比例风险模型分析预后因素。单因素分析有意义的变量通过R studio软件(版本号3.5.1)构建预测列线图。结果194例食管癌肺转移患者中位生存时间为7.0个月,3个月生存率为69.9%,1年生存率为27.7%。年龄(HR=1.51,95%CI:1.066~2.140)、病理类型(HR=0.736,95%CI:0.543~0.998)为食管癌肺转移患者预后的独立影响因素。列线图C-index值为0.634(95%CI:0.585~0.683)。结论对于食管癌肺转移患者,年轻、病理类型为腺癌与更好的预后相关。列线图的预测效果良好。 Objective To establish a prediction model for the prognosis of patients with esophageal cancer lung metastasis.Methods Data from 194 patients with esophageal cancer lung metastasis from 2010 to 2015 was collected from the National Cancer Institute Surveillance, Epidemiology and End Results(SEER) database. The best cutoff value for age was determined by X-tile software.Prognostic factors were analyzed by SPSS(v25.0) with the log-rank method and the Cox proportional hazard model. Risk factors from univariate analysis were used to construct prediction nomogram with R studio software(version 3.5.1). Results The median survival time of 194 patients with esophageal cancer lung metastasis was 7.0 months, the 3-month survival rate was 69.9%, and the 1-year survival rate was 27.7%. Age(HR=1.51, 95% CI: 1.066-2.140) and pathological type(HR=0.736, 95% CI: 0.543-0.998) were independent prognostic factors for patients with esophageal cancer lung metastasis. The value of C-index was 0.634(95% CI=0.585-0.683). Conclusion For patients with esophageal cancer lung metastasis, being young and adenocarcinoma are associated with a better prognosis. The prediction of the nomogram is good.
作者 程志远 张啸天 孟茜茜 王天骄 林寒 辛磊 张玲 王洛伟 李兆申 CHENG Zhi-yuan;ZHANG Xiao-tian;MENG Qian-qian;WANG Tian-jiao;LIN Han;XIN Lei;ZHANG Ling;WANG Luo-wei;LI Zhao-shen(College of Basic Medical Sciences,Naval Medical University,Shanghai 200433,China)
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2019年第7期613-617,共5页 Chinese Journal of Practical Internal Medicine
关键词 食管癌 肿瘤转移:SEER数据库 预后分析 esophageal cancer neoplasm metastasis SEER database prognosis analysis lung
  • 相关文献

参考文献4

二级参考文献34

  • 1黄镜,蔡锐刚,孟平均,张明娟,崔成旭,杨林,储大同,孙燕,王金万.紫杉醇联合顺铂治疗晚期食管鳞癌[J].中华肿瘤杂志,2004,26(12):753-755. 被引量:96
  • 2中国肿瘤防治研究办公室卫生部统计信息中心.中国试点市、县恶性肿瘤的发病与死亡[M].北京:中国医药科技出版社,2002.28-34.
  • 3Dinwoodie W R, Bartolucci A A, Lyman G H, et al. Phase Ⅱ evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group Trim [J]. Cancer Treat Rep, 1986,70 (2) : 267 -270.
  • 4Kelsen D, Hilaris B, Coonley C, et al. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma [J]. Am J Med, 1983,75(4):645-652.
  • 5De Besi P, Salvagno L, Endrizzi L, et al. Cisplatin, bleomycin and methotrexate in the treatment of advanced oesophageal cancer [J]. Eur J Cancer Clin Oncol, 1984,20 (6) : 743 -747.
  • 6Kelsen D P, Fein R, Coonley C, et al. Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer [J]. Cancer Treat Rep, 1986,70(2) :255-259.
  • 7Vogl S E, Greenwald E, Kaplan B H. Effective chemotherapy for esophageal cancer with methotrexate, bleomycin, and cisdiamminedichloroplatinum Ⅱ[J]. Cancer, 1981,48(12): 2555-2558.
  • 8Bleiberg H, Convoy T, Paillot B, et al. Randomised phase Ⅱ study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer [J]. Eur J Cancer, 1997,33 (8) : 1216-1220.
  • 9Conroy T, Etienne P L, Adenis A, et al. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival [J]. Ann Oncol, 2002,13(5) :721-729.
  • 10Polee M B, Kok T C, Siersema P D, et al. Phase Ⅱ study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus [J].Anticancer Drugs, 2001,12(6) :513-517.

共引文献238

同被引文献14

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部